Pneumococcal vaccination does not increase circulating levels of IgM antibodies to oxidized LDL in humans and therefore precludes an anti-atherogenic effect
Authors:
- Jan DamoiseauxJDJan Damoiseaux
- Ger RijkersGRGer Rijkers
- Jan Willem Cohen TervaertJTJan Willem Cohen Tervaert
- 1 January 2007
- journal article
- other
- Published by Elsevier in Atherosclerosis
- Vol. 190 (1) , 10-11
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Cross‐Reactivity of IgM and IgG Anticardiolipin Antibodies with Oxidized‐Low Density LipoproteinsAnnals of the New York Academy of Sciences, 2005
- Human innate B cells: a link between host defense and autoimmunity?Springer Seminars in Immunopathology, 2005
- Immunoglobulin M Type of Autoantibodies to Oxidized Low-Density Lipoprotein Has an Inverse Relation to Carotid Artery AtherosclerosisCirculation, 2003
- Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDLNature Medicine, 2003
- Antibodies to Oxidized LDL in Relation to Carotid Atherosclerosis, Cell Adhesion Molecules, and Phospholipase A 2Arteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Immunoglobulin Isotype-Specific Antibody Responses to Pneumococcal Polysaccharide Vaccine in Patients with Recurrent Bacterial Respiratory Tract InfectionsPediatric Research, 1995
- Pneumococcal Polysaccharide Vaccine in Young Adults and Older Bronchitics: Determination of IgG Responses by ELISA and the Effect of Adsorption of Serum with Non-Type-Specific Cell Wall PolysaccharideThe Journal of Infectious Diseases, 1990